Abstract
dc:description.abstractA better understanding of the mechanisms that modulate opioid antinociception and tolerance could lead to the development of novel pain medications with reduced abuse potential. The transmembrane glycoprotein CD38, is important for intracellular calcium homeostasis and has been linked to supraspinal opioid antinociception and tolerance, but its role in spinal opioid antinociception and tolerance remains unknown. We hypothesized that CD38-dependent signaling cascades in the spinal cord are involved in chronic pain development as well as opioid-induced antinociception, tolerance, hyperalgesia and reward. To test this, we measured pain thresholds in response to intrathecal morphine administration. Nociceptive thresholds in naïve mice were obtained in response to thermal and mechanical stimuli using the warm water tail immersion test (TIT) and the tail pressure test (TPT) in male and female wildtype (WT) and CD38 knockout (CD38KO) mice. Mechanical hypersensitivity in the spared nerve injury model (SNI) of chronic neuropathic pain was measured using von Frey filaments. We used the conditioned-place preference (CPP) model to assess the role of CD38 in opioid-induced reward. Results showed that lack of CD38 did not alter pretreatment basal pain levels but decreased opioid efficacy in males and females and had a role in opioid-induced thermal hyperalgesia in females but not males. No effect was observed in CD38KO mice in opioid-induced tolerance or on the development of chronic neuropathic pain based on the SNI model, but morphine spinal antinociceptive potency was reduced in CD38KO mice with or without SNI with a stronger effect on males. In addition, CD38 prevented reinstatement of morphine-evoked CPP in male but not female mice, suggesting the existence of a sex-specific role for CD38 in opioid-evoked reward mechanisms. In-situ hybridization and immunohistochemistry performed in spinal cord tissues from wild type mice revealed that CD38 is localized mainly in GFAP positive cells, which suggests expression mainly in astrocytes. The results presented in this dissertation have revealed CD38 as a novel modulator of spinal opioid signaling cascades with relevance to neuron-astrocyte communication.
Author and committee
dc:creator, dc:contributor.*- Author dc:creator
-
- Quintana Rivera, Ruth
Subjects
dc:subject × 6Rights
- Language dc:language.iso
- en
Identifiers
dc:identifier.*- Dc Identifier Citation
- Quintana Rivera, Ruth. (2025). Role Of Astrocytic CD38 In Spinal Opioid Signaling. Retrieved from the University Digital Conservancy, https://hdl.handle.net/11299/279271.